Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,603 public trials 2,148 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Active, Not Recruiting

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

NCT05783622

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +46 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Atrasentan in Patients With Proteinuric Glomerular Diseases

NCT04573920

Conditions
Alport Syndrome, Autoimmune Diseases, Collagen Diseases, +26 more
Locations
  • Kidney Disease Medical Group Glendale, California, United States
  • Academic Medical Research Institute Los Angeles, California, United States
  • North America Research Institute San Dimas, California, United States
  • Stanford U School Of Medicine Stanford, California, United States
View all 33 locations
View Trial Details
Active, Not Recruiting

The Arteriovenous Vascular (AV) ACCESS Trial

NCT04646226

Conditions
Chronic Disease, Disease Attributes, End-stage Kidney Disease, +12 more
Locations
  • University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States
  • UCLA Los Angeles, California, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
  • Atrium Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States
View Trial Details
Active, Not Recruiting

A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD

NCT05281328

Conditions
Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, +13 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • Mount Sinai Hospital New York, United States
  • The New York Presbyterian Hospital New York, United States
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

NCT04514484

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer

NCT03682068

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +10 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bakersfield, California, United States
  • Research Site Fullerton, California, United States
  • Research Site Los Angeles, California, United States
View all 222 locations
View Trial Details

Related conditions